Lake Bleu Capital Asset Manager Profile - aVenture Research
Lake Bleu Capital is a Hong Kong-based investment firm specializing in the healthcare sector. The firm typically invests in later-stage rounds, including Series B, Series C, and private equity rounds. Their investment focus is on innovative healthcare companies that have the potential to make significant impacts in their fields.
Notable portfolio companies include AffaMed Therapeutics, Brii Biosciences, Insilico Medicine, and MicroPort CardioFlow, which have collectively raised substantial funding. Lake Bleu Capital is known for its deep industry expertise and strategic support, providing value-add services that go beyond capital investment to help portfolio companies achieve their growth objectives.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
